Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection (ENACOVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04325633
Recruitment Status : Terminated (Stop inclusions for insufficient recruitment)
First Posted : March 27, 2020
Last Update Posted : February 25, 2021
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 15, 2020
Actual Study Completion Date : December 15, 2020